Exodus Point Capital Management, LP Akebia Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 133,934 shares of AKBA stock, worth $304,030. This represents 0.0% of its overall portfolio holdings.
Number of Shares
133,934Holding current value
$304,030% of portfolio
0.0%Shares
9 transactions
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $417M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...